Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.
This Week’s Highlights
Amboy Street Ventures closes its $20M debut fund dedicated to women’s health and sexual wellness.
Indian DTC startup Gynoveda raises $10M in Series A funding for its Ayurveda-based women’s health treatments.
Iron Health launches with $4.5M in seed funding to support OB/GYNs and close gaps in women’s health.
Biotech startup theblood raises close to €1M in pre-seed funding for its menstrual blood testing solution and biomarker research.
Berlin-based menstrual health startup HERMONE launches with €1M in pre-seed funding.
Melinda Gates’ Pivotal Ventures invests in women’s health scale-up Tia.
Sumitovant Biopharma acquires women’s health pharma company Myovant Sciences for $1.7B.
Visby‘s second generation point-of-care STI test receives FDA clearance.
Google Health AI announces new women’s health partnerships.
Celmatix and global collaborators release findings from the to date largest genetic study on endometriosis.
In the Know
Bone Health, Osteoporosis & Innovation (Femtech Insider)
5 Best-Practices for YouTube Health Content Creators (Femtech Insider)
Fertility companies Legacy and Carrot team up to release “The Sperm Report” (Femtech Insider)
Menstruation to fertility: Femtech is booming (DW)
Can Any Amount of Money Turn the Tide on Global Fertility? (Washington Post)
AI chatbots can improve health – but only with help from humans (STAT News)
‘OK’ isn’t an acceptable answer for women’s health in America (The Hill)
The tech helping women manage the menopause (BBC)
Dating in the Metaverse (Proto.Life)
The Future of Fertility Technology, From Technosemen to Uterine Transplants (MIT Press)
